0001179110-15-014738.txt : 20151112 0001179110-15-014738.hdr.sgml : 20151112 20151112084150 ACCESSION NUMBER: 0001179110-15-014738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151110 FILED AS OF DATE: 20151112 DATE AS OF CHANGE: 20151112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ONETTO NICOLE CENTRAL INDEX KEY: 0001220049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 151221684 MAIL ADDRESS: STREET 1: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 4 1 edgar.xml FORM 4 - X0306 4 2015-11-10 0 0000855654 IMMUNOGEN INC IMGN 0001220049 ONETTO NICOLE ONTARIO INSTITUTE FOR CANCER RESEARCH 101 COLLEGE STREET, SUITE 800 TORONTO A6 M5G 0A3 ONTARIO, CANADA 1 0 0 0 Deferred Share Unit 0 2015-11-10 4 A 0 3000 0 A 2016-02-01 Common Stock 3000 53248 D Stock option (right to buy) 13.07 2015-11-10 4 A 0 10000 13.07 A 2016-02-01 2025-11-10 Common Stock 10000 10000 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest ratably over a one year period in quarterly increments beginning on February 1, 2016, contingent upon the individual remaining a director as of each vesting date. Exercisable as to 2,500 shares commencing on February 1, 2016, 2,500 shares commencing on May 1, 2016, 2,500 shares commencing on August 1, 2016 and 2,500 shares commencing on November 1, 2016, contingent upon the individual remaining a director as of each vesting date. /s/ Craig Barrows, attorney in fact. 2015-11-12